The causes and mechanisms of the initial trident neuropsychiatric pains are not known, but they are mostly considered to be in the vicinity of the trident neurons, i.e., in the root of the trident neurosynthesis. It may be associated with small vascular malformations, bone deformities in the core, etc., causing pain. The drug that is more commonly used is anti-eclampsia.
Traditional drugs for trident neuropsychiatric pain are currently mainly anti-eclampsia drugs, with more evidence-based research in the country. For the recent effects of tridental treatments in Ramo and Camasipine, a new generation of epilepsy drug Ramo monopharmaceutical treatments have some degree of efficacy and less adverse effects, but their long-term, integrated treatments have good effects in Kamasipine.
A common drug for trident nerve pain.
The usual drug, Qamasipin, should be taken at a minimum dose, starting at a rate of 0.1 g per day and two times per day; if pain relief is minimal, it can be increased by 0.1 to 0.2 g per day every second day after the following day, until pain relief is achieved, with maintenance of 0.4 to 0.8 g per day, with a maximum of 1.2 g per day and a specific dose to be carried out under the direction of a doctor.
Okassipine dosages 300 mg/day, 2 times a day. Usage: Increased until pain is reduced gradually, effective maintenance 600-1200 mg/day, maximum dose at 1800 mg/d for 4-12 weeks, stop if symptoms such as dizziness and vomiting affect normal life.
Sodium acetate: initial dosage 0.4g three times a day, after pain has been reduced, then the 14d will continue and then be reduced as appropriate until it is completely eliminated.
Lamorium: 25 mg per day, plus 25 mg per day between 3 and 7 days, to maintain 300-400 mg/day.
Sodium benzo-p-mg: 100 mg for first use, in two oral doses, which can slowly increase to 30-60 mg/day and maintain a dose of 300-500 mg/day.
PV: 200-300 mg/day, 1 000-4000 mg/day, 1 day, depending on the condition, 300 mg/day, 300 mg/day, with a gradual increase of 300 mg/day, if sustained, to 1800 mg/day.
Dr. Wang Zing, Tangdu Hospital, reminds that patients with trident neuropsychiatric pain are treated through drug regulation, with no maximum dose being able to control the condition, and must not over-dependent on the medication and overdose, leading to other complications, at which point they need to resort to microvascular repressure for treatment.
